Kidney Research UK

We’re on the lookout for a senior communications officer – social media for a 12-month fixed-term contract (maternity cover). If you’re a team player with a passion for storytelling and a proven ability to craft content that engages, educates, and sparks conversation across multiple social media platforms, we’d love to hear from you. Read the full job description and apply here: https://bit.ly/4hiLwrg Please share with your network or tag them in the comments below.

“Kidney transplant recipients are at over three times greater risk of bladder cancer.” Dr Simon Baker at the University of York suggests that BK virus can trigger changes in DNA that drive bladder cancer development. BK virus is a common virus that nearly everyone picks up in childhood generally without noticing which can hide in the kidneys without causing symptoms. Reactivation of BK virus can happen in kidney transplant recipients due to their immunosuppressive medication. Simon and his team will now look for an antiviral treatment to target BK virus and help prevent the development of bladder cancer in kidney transplant patients. To read the full story, click here: https://bit.ly/4pjXEvr The study was jointly funded with York Against Cancer

Can specialised eye scans be used to monitor kidney disease progression? Currently, monitoring kidney health often relies on blood tests and, in some cases, biopsies, both of which can be invasive and uncomfortable. In December 2023 we shared the promising results from a study by Professors Neeraj Dhaun (Bean), Matt Bailey, and the team at the University of Edinburgh, who showed that specialised eye scans, called optical coherence tomography (OCT) could be used to monitor kidney disease progression. With further funding, the team are now working on experiments in the lab to see if there were changes to the eye that happened following acute kidney injury (AKI), and whether the eye shows improvement when kidney function improves due to treatment. “This is an important next step to validate our methodology and demonstrate its effectiveness in models of kidney disease, paving the way for potential clinical applications.” Bean. Read more: https://bit.ly/47J8IL2

We are excited to have appointed Dr David Crosby as our new chief research officer, finalising our strengthened executive team as we move ahead with our ambitious plans to transform kidney care in the UK. David joins chief income and engagement officer, Lucy Sreeves, and recently appointed Mike Bishop, our first chief operating officer, in reporting directly into our CEO Sandra Currie. These new appointments are pivotal as we move into the next phase of our ten-year strategy in which the charity is expanding to combat the growing crisis in kidney care. With kidney disease affecting around one in ten people in the UK, our focus on impact, driving research to transform patients' lives, is more vital than ever. “𝐾𝑖𝑑𝑛𝑒𝑦 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑖𝑠 𝑎𝑛 𝑜𝑣𝑒𝑟𝑤ℎ𝑒𝑙𝑚𝑖𝑛𝑔𝑙𝑦 𝑢𝑛𝑚𝑒𝑡 𝑛𝑒𝑒𝑑. 𝑇𝑜𝑜 𝑜f𝑡𝑒𝑛, 𝑝𝑟𝑜𝑔𝑟𝑒𝑠𝑠 𝑙𝑎𝑔𝑠 𝑏𝑒ℎ𝑖𝑛𝑑 𝑜𝑡ℎ𝑒𝑟 𝑎𝑟𝑒𝑎𝑠 𝑜f ℎ𝑒𝑎𝑙𝑡ℎ 𝑟𝑒𝑠𝑒𝑎𝑟𝑐ℎ. 𝐼 𝑤𝑎𝑛𝑡 𝑡𝑜 ℎ𝑒𝑙𝑝 𝑐ℎ𝑎𝑛𝑔𝑒 𝑡ℎ𝑎𝑡 – 𝑏𝑢𝑖𝑙𝑑𝑖𝑛𝑔 𝑜𝑛 𝐾𝑖𝑑𝑛𝑒𝑦 𝑅𝑒𝑠𝑒𝑎𝑟𝑐ℎ 𝑈𝐾’𝑠 𝑠𝑡𝑟𝑜𝑛𝑔 f𝑜𝑢𝑛𝑑𝑎𝑡𝑖𝑜𝑛𝑠 𝑡𝑜 𝑏𝑟𝑖𝑛𝑔 𝑛𝑒𝑤 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡𝑠 𝑎𝑛𝑑 𝑑𝑖𝑎𝑔𝑛𝑜𝑠𝑡𝑖𝑐𝑠 𝑡𝑜 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 f𝑎𝑠𝑡𝑒𝑟.” - 𝗗𝗿 𝗗𝗮𝘃𝗶𝗱 𝗖𝗿𝗼𝘀𝗯𝘆 Read more: https://bit.ly/43en9p0

With data from 3,000 CKD patients, 740 INS patients, and from AKI patients in progress, find out how NURTuRE can excel your research. All samples and data are held securely, and researchers apply for access through our website. All applications will be reviewed by the NURTuRE strategy group. Take the next steps in transforming the lives of kidney patients. Apply now to access NURTuRE samples and data.

Are you an academic or commercial researcher? The need for innovation in diagnosis, prevention, and better management of kidney disease has never been greater. With access to healthcare data and biological samples, NURTuRE can support you today. Explore what NURTuRE can help you achieve.